Sec Form 4/A Filing - Sell Steven @ agilon health, inc. - 2023-04-14

FORM 4/A Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Sell Steven 2. Issuer Name and Ticker or Trading Symbol agilon health, inc. [ AGL] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X __ Director _____ 10% Owner X __ Officer (give title below) _____ Other (specify below) CEO & President (Last) (First) (Middle) C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450 3. Date of Earliest Transaction (MM/DD/YY) 04/14/2023 (Street) AUSTIN, TX78723 4. If Amendment, Date Original Filed (MM/DD/YY) 04/18/2023 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 04/14/2023 A 39,530 ( 1 ) ( 2 ) A $ 0 88,295 ( 2 ) ( 3 ) D Common Stock 04/14/2023 F 4,216 ( 4 ) D $ 28.46 84,079 ( 2 ) ( 3 ) D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Options (Right to buy) $ 28.46 04/14/2023 A 68,348 ( 5 ) ( 5 ) 04/14/2033( 6 ) Common Stock 68,348 ( 5 ) $ 0 68,348 ( 5 ) D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Sell Steven C/O AGILON HEALTH, INC. 6210 E HWY 290, SUITE 450 AUSTIN, TX78723 X CEO & President Signatures /s/ Steve Meetre, as Attorney-in-Fact 06/16/2023 Signature of Reporting Person Date

Explanation of Responses:

( 1 )Restricted stock units that vest in four equal installments on each anniversary of April 14, 2023, subject to continued employment. ( 2 )This Form 4/A amends a Form 4 filed by the reporting person on April 18, 2023 (the "Original Form 4"), which reported a grant of restricted stock units on April 14, 2023. The Original Form 4 erroneously reported a grant of 35,138 restricted stock units, rather than the actual grant of 39,530 restricted stock units. This error in the Original Form 4 has been corrected in this Form 4/A. ( 3 )Includes restricted stock units. ( 4 )Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale. ( 5 )The Original Form 4 erroneously reported that a stock option grant to the reporting person on April 14, 2023 was for 60,754 share of Common Stock, rather than the actual stock option grant for 68,348 shares of Common Stock. This error on the Original Form 4 has been corrected in this Form 4/A. ( 6 )Options that vest in four equal installments on each anniversary of April 14, 2023, subject to continued employment.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.